| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP-dependent diacylglycerol kinase activity | 2.69e-07 | 11 | 109 | 4 | GO:0004143 | |
| GeneOntologyMolecularFunction | lipid kinase activity | 2.83e-06 | 41 | 109 | 5 | GO:0001727 | |
| GeneOntologyMolecularFunction | retinoic acid binding | 1.55e-05 | 28 | 109 | 4 | GO:0001972 | |
| GeneOntologyMolecularFunction | glutamine N-acyltransferase activity | 2.95e-05 | 2 | 109 | 2 | GO:0047946 | |
| GeneOntologyMolecularFunction | P-type manganese transporter activity | 2.95e-05 | 2 | 109 | 2 | GO:0140613 | |
| GeneOntologyMolecularFunction | protein kinase C binding | 3.03e-05 | 66 | 109 | 5 | GO:0005080 | |
| GeneOntologyMolecularFunction | glucuronosyltransferase activity | 3.86e-05 | 35 | 109 | 4 | GO:0015020 | |
| GeneOntologyMolecularFunction | retinoid binding | 1.36e-04 | 48 | 109 | 4 | GO:0005501 | |
| GeneOntologyMolecularFunction | isoprenoid binding | 1.47e-04 | 49 | 109 | 4 | GO:0019840 | |
| GeneOntologyMolecularFunction | kinase binding | MYOM1 UGT1A10 UGT1A8 UGT1A7 GAS6 SHC1 UGT1A9 DGKQ DGKD DGKH ACE HDAC7 EEF1A2 PER2 BANK1 | 2.48e-04 | 969 | 109 | 15 | GO:0019900 |
| GeneOntologyMolecularFunction | glycine N-acyltransferase activity | 2.92e-04 | 5 | 109 | 2 | GO:0047961 | |
| GeneOntologyMolecularFunction | fatty acid binding | 5.53e-04 | 69 | 109 | 4 | GO:0005504 | |
| GeneOntologyMolecularFunction | manganese ion transmembrane transporter activity | 1.29e-03 | 10 | 109 | 2 | GO:0005384 | |
| GeneOntologyMolecularFunction | P-type calcium transporter activity | 1.57e-03 | 11 | 109 | 2 | GO:0005388 | |
| GeneOntologyBiologicalProcess | estrogen catabolic process | 3.81e-09 | 5 | 110 | 4 | GO:0006711 | |
| GeneOntologyBiologicalProcess | phenylpropanoid catabolic process | 1.14e-08 | 6 | 110 | 4 | GO:0046271 | |
| GeneOntologyBiologicalProcess | coumarin catabolic process | 1.14e-08 | 6 | 110 | 4 | GO:0046226 | |
| GeneOntologyBiologicalProcess | flavone metabolic process | 1.14e-08 | 6 | 110 | 4 | GO:0051552 | |
| GeneOntologyBiologicalProcess | hormone catabolic process | 7.48e-08 | 21 | 110 | 5 | GO:0042447 | |
| GeneOntologyBiologicalProcess | phenylpropanoid metabolic process | 1.57e-07 | 10 | 110 | 4 | GO:0009698 | |
| GeneOntologyBiologicalProcess | coumarin metabolic process | 1.57e-07 | 10 | 110 | 4 | GO:0009804 | |
| GeneOntologyBiologicalProcess | lipid phosphorylation | 2.46e-07 | 11 | 110 | 4 | GO:0046834 | |
| GeneOntologyBiologicalProcess | flavonoid metabolic process | 5.28e-07 | 13 | 110 | 4 | GO:0009812 | |
| GeneOntologyBiologicalProcess | flavonoid glucuronidation | 1.46e-06 | 5 | 110 | 3 | GO:0052696 | |
| GeneOntologyBiologicalProcess | cellular glucuronidation | 4.27e-06 | 21 | 110 | 4 | GO:0052695 | |
| GeneOntologyBiologicalProcess | glucuronate metabolic process | 1.05e-05 | 26 | 110 | 4 | GO:0019585 | |
| GeneOntologyBiologicalProcess | uronic acid metabolic process | 1.05e-05 | 26 | 110 | 4 | GO:0006063 | |
| GeneOntologyBiologicalProcess | diacylglycerol metabolic process | 1.42e-05 | 28 | 110 | 4 | GO:0046339 | |
| GeneOntologyBiologicalProcess | xenobiotic glucuronidation | 3.14e-05 | 12 | 110 | 3 | GO:0052697 | |
| GeneOntologyBiologicalProcess | steroid catabolic process | 3.14e-05 | 34 | 110 | 4 | GO:0006706 | |
| GeneOntologyBiologicalProcess | phosphatidic acid biosynthetic process | 3.95e-05 | 36 | 110 | 4 | GO:0006654 | |
| GeneOntologyBiologicalProcess | phosphatidic acid metabolic process | 6.66e-05 | 41 | 110 | 4 | GO:0046473 | |
| GeneOntologyBiologicalProcess | xenobiotic metabolic process | 1.10e-04 | 141 | 110 | 6 | GO:0006805 | |
| GeneOntologyBiologicalProcess | estrogen metabolic process | 1.70e-04 | 52 | 110 | 4 | GO:0008210 | |
| GeneOntologyBiologicalProcess | cellular response to xenobiotic stimulus | 1.89e-04 | 222 | 110 | 7 | GO:0071466 | |
| GeneOntologyBiologicalProcess | secondary metabolic process | 4.53e-04 | 67 | 110 | 4 | GO:0019748 | |
| Domain | DAGK_acc | 2.24e-07 | 10 | 109 | 4 | PF00609 | |
| Domain | Diacylglycerol_kin_accessory | 2.24e-07 | 10 | 109 | 4 | IPR000756 | |
| Domain | DAGKa | 2.24e-07 | 10 | 109 | 4 | SM00045 | |
| Domain | DAGKc | 1.05e-06 | 14 | 109 | 4 | SM00046 | |
| Domain | Diacylglycerol_kinase_cat_dom | 1.43e-06 | 15 | 109 | 4 | IPR001206 | |
| Domain | DAGK_cat | 1.43e-06 | 15 | 109 | 4 | PF00781 | |
| Domain | DAGK | 1.43e-06 | 15 | 109 | 4 | PS50146 | |
| Domain | NAD/diacylglycerol_kinase | 2.46e-06 | 17 | 109 | 4 | IPR016064 | |
| Domain | UDPGT | 6.09e-06 | 21 | 109 | 4 | PF00201 | |
| Domain | UDPGT | 6.09e-06 | 21 | 109 | 4 | PS00375 | |
| Domain | UDP_glucos_trans | 6.09e-06 | 21 | 109 | 4 | IPR002213 | |
| Domain | P-type_ATPase_IIA_PMR1 | 3.37e-05 | 2 | 109 | 2 | IPR006413 | |
| Domain | ASD2 | 2.01e-04 | 4 | 109 | 2 | PF08687 | |
| Domain | ASD2 | 2.01e-04 | 4 | 109 | 2 | PS51307 | |
| Domain | Shroom_fam | 2.01e-04 | 4 | 109 | 2 | IPR027685 | |
| Domain | ASD2_dom | 2.01e-04 | 4 | 109 | 2 | IPR014799 | |
| Domain | C1_1 | 3.42e-04 | 57 | 109 | 4 | PF00130 | |
| Domain | cEGF | 4.56e-04 | 26 | 109 | 3 | IPR026823 | |
| Domain | cEGF | 4.56e-04 | 26 | 109 | 3 | PF12662 | |
| Domain | ZF_DAG_PE_1 | 5.33e-04 | 64 | 109 | 4 | PS00479 | |
| Domain | ZF_DAG_PE_2 | 5.33e-04 | 64 | 109 | 4 | PS50081 | |
| Domain | C1 | 5.65e-04 | 65 | 109 | 4 | SM00109 | |
| Domain | PE/DAG-bd | 5.99e-04 | 66 | 109 | 4 | IPR002219 | |
| Domain | fn3 | 2.61e-03 | 162 | 109 | 5 | PF00041 | |
| Domain | - | 3.84e-03 | 16 | 109 | 2 | 1.20.1110.10 | |
| Domain | ATPase_P-typ_TM_dom | 3.84e-03 | 16 | 109 | 2 | IPR023298 | |
| Domain | ATPase_P-typ_cation-transptr_C | 4.33e-03 | 17 | 109 | 2 | IPR006068 | |
| Domain | Cation_ATPase_C | 4.33e-03 | 17 | 109 | 2 | PF00689 | |
| Domain | FN3 | 4.60e-03 | 185 | 109 | 5 | SM00060 | |
| Domain | Laminin_G | 4.73e-03 | 58 | 109 | 3 | IPR001791 | |
| Domain | RUN | 4.86e-03 | 18 | 109 | 2 | SM00593 | |
| Domain | Cation_ATPase_N | 4.86e-03 | 18 | 109 | 2 | PF00690 | |
| Domain | Cation_ATPase_N | 4.86e-03 | 18 | 109 | 2 | SM00831 | |
| Domain | RUN | 5.41e-03 | 19 | 109 | 2 | PS50826 | |
| Domain | RUN | 5.41e-03 | 19 | 109 | 2 | PF02759 | |
| Domain | ATPase_P-typ_cation-transptr_N | 5.41e-03 | 19 | 109 | 2 | IPR004014 | |
| Domain | Run_dom | 5.41e-03 | 19 | 109 | 2 | IPR004012 | |
| Pathway | WP_ESTROGEN_METABOLISM | 6.92e-08 | 22 | 71 | 5 | MM15888 | |
| Pathway | REACTOME_ASPIRIN_ADME | 2.62e-06 | 44 | 71 | 5 | M45014 | |
| Pathway | REACTOME_ASPIRIN_ADME | 2.93e-06 | 45 | 71 | 5 | MM15694 | |
| Pathway | KEGG_DRUG_METABOLISM_OTHER_ENZYMES | 5.51e-06 | 51 | 71 | 5 | M17726 | |
| Pathway | REACTOME_GLUCURONIDATION | 5.82e-06 | 24 | 71 | 4 | MM14599 | |
| Pathway | REACTOME_GLUCURONIDATION | 6.90e-06 | 25 | 71 | 4 | M17787 | |
| Pathway | WP_GLUCURONIDATION | 6.90e-06 | 25 | 71 | 4 | MM15820 | |
| Pathway | REACTOME_EFFECTS_OF_PIP2_HYDROLYSIS | 6.90e-06 | 25 | 71 | 4 | MM14511 | |
| Pathway | KEGG_ASCORBATE_AND_ALDARATE_METABOLISM | 6.90e-06 | 25 | 71 | 4 | M605 | |
| Pathway | WP_GLUCURONIDATION | 8.12e-06 | 26 | 71 | 4 | M39404 | |
| Pathway | REACTOME_EFFECTS_OF_PIP2_HYDROLYSIS | 9.50e-06 | 27 | 71 | 4 | M12123 | |
| Pathway | KEGG_PENTOSE_AND_GLUCURONATE_INTERCONVERSIONS | 1.10e-05 | 28 | 71 | 4 | M19580 | |
| Pathway | REACTOME_BIOLOGICAL_OXIDATIONS | 1.42e-05 | 220 | 71 | 8 | M10320 | |
| Pathway | KEGG_RETINOL_METABOLISM | 1.70e-05 | 64 | 71 | 5 | M9488 | |
| Pathway | REACTOME_DRUG_ADME | 1.77e-05 | 109 | 71 | 6 | M45012 | |
| Pathway | WP_IRINOTECAN_PATHWAY | 2.61e-05 | 12 | 71 | 3 | M39611 | |
| Pathway | REACTOME_PARACETAMOL_ADME | 4.25e-05 | 39 | 71 | 4 | MM15695 | |
| Pathway | WP_CODEINE_AND_MORPHINE_METABOLISM | 4.28e-05 | 14 | 71 | 3 | M39328 | |
| Pathway | KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM | 5.20e-05 | 41 | 71 | 4 | M7399 | |
| Pathway | WP_2Q37_COPY_NUMBER_VARIATION_SYNDROME | 8.82e-05 | 145 | 71 | 6 | M45512 | |
| Pathway | KEGG_GLYCEROLIPID_METABOLISM | 1.05e-04 | 49 | 71 | 4 | M15902 | |
| Pathway | REACTOME_BIOLOGICAL_OXIDATIONS | 1.14e-04 | 219 | 71 | 7 | MM14838 | |
| Pathway | KEGG_STARCH_AND_SUCROSE_METABOLISM | 1.33e-04 | 52 | 71 | 4 | M14171 | |
| Pathway | KEGG_STEROID_HORMONE_BIOSYNTHESIS | 1.66e-04 | 55 | 71 | 4 | M14933 | |
| Pathway | REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS | 2.19e-04 | 109 | 71 | 5 | M18788 | |
| Pathway | REACTOME_DRUG_ADME | 3.29e-04 | 119 | 71 | 5 | MM15692 | |
| Pathway | KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450 | 4.22e-04 | 70 | 71 | 4 | M16794 | |
| Pathway | KEGG_DRUG_METABOLISM_CYTOCHROME_P450 | 4.69e-04 | 72 | 71 | 4 | M9257 | |
| Pathway | KEGG_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM | 5.77e-04 | 76 | 71 | 4 | M9052 | |
| Pathway | KEGG_GLYCEROPHOSPHOLIPID_METABOLISM | 6.06e-04 | 77 | 71 | 4 | M9131 | |
| Pathway | REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS | 6.51e-04 | 210 | 71 | 6 | MM15043 | |
| Pathway | REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS | 7.73e-04 | 217 | 71 | 6 | M18437 | |
| Pathway | WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2873 | 1.49e-03 | 45 | 71 | 3 | M39615 | |
| Pubmed | 1.69e-09 | 6 | 115 | 4 | 32527940 | ||
| Pubmed | 1.69e-09 | 6 | 115 | 4 | 20297805 | ||
| Pubmed | Genome-wide association of serum bilirubin levels in Korean population. | 2.17e-09 | 17 | 115 | 5 | 20639394 | |
| Pubmed | Assignment of the human UDP glucuronosyltransferase gene (UGT1A1) to chromosome region 2q37. | 3.94e-09 | 7 | 115 | 4 | 8467709 | |
| Pubmed | 3.94e-09 | 7 | 115 | 4 | 8464825 | ||
| Pubmed | 3.94e-09 | 7 | 115 | 4 | 27514509 | ||
| Pubmed | A genome-wide assessment of variability in human serum metabolism. | 4.06e-09 | 19 | 115 | 5 | 23281178 | |
| Pubmed | 7.86e-09 | 8 | 115 | 4 | 20610558 | ||
| Pubmed | 7.86e-09 | 8 | 115 | 4 | 18052087 | ||
| Pubmed | 7.86e-09 | 8 | 115 | 4 | 17179145 | ||
| Pubmed | 1.41e-08 | 9 | 115 | 4 | 22511988 | ||
| Pubmed | Genetic determinants influencing human serum metabolome among African Americans. | 1.46e-08 | 24 | 115 | 5 | 24625756 | |
| Pubmed | 2.35e-08 | 10 | 115 | 4 | 23642732 | ||
| Pubmed | 2.35e-08 | 10 | 115 | 4 | 11465080 | ||
| Pubmed | 2.35e-08 | 10 | 115 | 4 | 23371916 | ||
| Pubmed | A genome-wide association study of total bilirubin and cholelithiasis risk in sickle cell anemia. | 2.35e-08 | 10 | 115 | 4 | 22558097 | |
| Pubmed | 3.52e-08 | 3 | 115 | 3 | 23949095 | ||
| Pubmed | 3.52e-08 | 3 | 115 | 3 | 12847094 | ||
| Pubmed | 3.52e-08 | 3 | 115 | 3 | 29519853 | ||
| Pubmed | 3.68e-08 | 11 | 115 | 4 | 17021016 | ||
| Pubmed | Role of UDP-glucuronosyltransferase isoforms in 13-cis retinoic acid metabolism in humans. | 5.50e-08 | 12 | 115 | 4 | 20308471 | |
| Pubmed | 5.50e-08 | 12 | 115 | 4 | 19419973 | ||
| Pubmed | Thirteen UDPglucuronosyltransferase genes are encoded at the human UGT1 gene complex locus. | 5.50e-08 | 12 | 115 | 4 | 11434514 | |
| Pubmed | UGT1A1 is a major locus influencing bilirubin levels in African Americans. | 7.93e-08 | 13 | 115 | 4 | 22085899 | |
| Pubmed | Genome-wide analysis of hepatic lipid content in extreme obesity. | 7.93e-08 | 13 | 115 | 4 | 25246029 | |
| Pubmed | 1.11e-07 | 14 | 115 | 4 | 21646302 | ||
| Pubmed | Human UDP-glucuronosyltransferases: metabolism, expression, and disease. | 1.11e-07 | 14 | 115 | 4 | 10836148 | |
| Pubmed | 1.11e-07 | 14 | 115 | 4 | 9295054 | ||
| Pubmed | Multiple variable first exons: a mechanism for cell- and tissue-specific gene regulation. | 1.11e-07 | 14 | 115 | 4 | 14672974 | |
| Pubmed | 1.41e-07 | 4 | 115 | 3 | 17558305 | ||
| Pubmed | Genome-wide association meta-analysis for total serum bilirubin levels. | 2.00e-07 | 16 | 115 | 4 | 19414484 | |
| Pubmed | 3.35e-07 | 18 | 115 | 4 | 20056724 | ||
| Pubmed | 3.50e-07 | 5 | 115 | 3 | 20565459 | ||
| Pubmed | 3.50e-07 | 5 | 115 | 3 | 15057901 | ||
| Pubmed | Human metabolic individuality in biomedical and pharmaceutical research. | 1.32e-06 | 57 | 115 | 5 | 21886157 | |
| Pubmed | Family-based genome-wide association scan of attention-deficit/hyperactivity disorder. | 2.92e-06 | 9 | 115 | 3 | 20732626 | |
| Pubmed | 5.70e-06 | 11 | 115 | 3 | 18695635 | ||
| Pubmed | Comprehensive pharmacogenetic analysis of irinotecan neutropenia and pharmacokinetics. | 7.58e-06 | 12 | 115 | 3 | 19349540 | |
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 27590316 | ||
| Pubmed | Identification and characterization of two splice variants of human diacylglycerol kinase eta. | 1.08e-05 | 2 | 115 | 2 | 12810723 | |
| Pubmed | Secretory pathway Ca2+ -ATPases promote in vitro microcalcifications in breast cancer cells. | 1.08e-05 | 2 | 115 | 2 | 28618103 | |
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 9438377 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 11677206 | ||
| Pubmed | Studies on the substrate specificity of human intestinal UDP- lucuronosyltransferases 1A8 and 1A10. | 1.08e-05 | 2 | 115 | 2 | 10497143 | |
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 12944498 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 16332677 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 17529886 | ||
| Pubmed | Association between MUC5B and TERT polymorphisms and different interstitial lung disease phenotypes. | 1.08e-05 | 2 | 115 | 2 | 24434656 | |
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 36912407 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 24673545 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 8626538 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 25547628 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 28594978 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 11901093 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 22031623 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 18568343 | ||
| Pubmed | Human UGT1A8 and UGT1A10 mRNA are expressed in primary human hepatocytes. | 1.08e-05 | 2 | 115 | 2 | 17603215 | |
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 15709193 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 9647757 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 20089735 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 31653936 | ||
| Pubmed | 1.91e-05 | 16 | 115 | 3 | 20972438 | ||
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 19717561 | ||
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 16636344 | ||
| Pubmed | Glucuronidation of psilocin and 4-hydroxyindole by the human UDP-glucuronosyltransferases. | 3.24e-05 | 3 | 115 | 2 | 20007669 | |
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 19244109 | ||
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 23267072 | ||
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 19225446 | ||
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 17406868 | ||
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 19996319 | ||
| Pubmed | Aquaporin 5 expression increases mucin production in lung adenocarcinoma. | 3.24e-05 | 3 | 115 | 2 | 21455588 | |
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 19364970 | ||
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 23721685 | ||
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 26247833 | ||
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 17339869 | ||
| Pubmed | Differences in UGT1A1, UGT1A7, and UGT1A9 polymorphisms between Uzbek and Japanese populations. | 3.24e-05 | 3 | 115 | 2 | 24453052 | |
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 23789755 | ||
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 16397224 | ||
| Pubmed | Store-independent activation of Orai1 by SPCA2 in mammary tumors. | 3.24e-05 | 3 | 115 | 2 | 20887894 | |
| Pubmed | 4.22e-05 | 190 | 115 | 6 | 24816252 | ||
| Pubmed | 6.48e-05 | 4 | 115 | 2 | 18946804 | ||
| Pubmed | Targeting Tyro3 ameliorates a model of PGRN-mutant FTLD-TDP via tau-mediated synaptic pathology. | 6.48e-05 | 4 | 115 | 2 | 29382817 | |
| Pubmed | 6.48e-05 | 4 | 115 | 2 | 16684770 | ||
| Pubmed | 6.48e-05 | 4 | 115 | 2 | 9271343 | ||
| Pubmed | 6.48e-05 | 4 | 115 | 2 | 23700788 | ||
| Pubmed | Chromosomal mapping of a human phenol UDP-glucuronosyltransferase, GNT1. | 6.48e-05 | 4 | 115 | 2 | 2108603 | |
| Pubmed | SPCA2 regulates Orai1 trafficking and store independent Ca2+ entry in a model of lactation. | 6.48e-05 | 4 | 115 | 2 | 23840669 | |
| Pubmed | The central clock controls the daily rhythm of Aqp5 expression in salivary glands. | 6.48e-05 | 4 | 115 | 2 | 28484984 | |
| Pubmed | 6.48e-05 | 4 | 115 | 2 | 20147615 | ||
| Pubmed | Nuclear diacylglycerol kinase-theta is activated in response to alpha-thrombin. | 6.48e-05 | 4 | 115 | 2 | 11309392 | |
| Pubmed | 6.48e-05 | 4 | 115 | 2 | 20628391 | ||
| Pubmed | 6.48e-05 | 4 | 115 | 2 | 17509819 | ||
| Pubmed | A new standard nomenclature for proteins related to Apx and Shroom. | 6.48e-05 | 4 | 115 | 2 | 16615870 | |
| Pubmed | 6.98e-05 | 66 | 115 | 4 | 19898482 | ||
| Pubmed | Genome-wide association study identifies multiple loci associated with bladder cancer risk. | 8.66e-05 | 26 | 115 | 3 | 24163127 | |
| Pubmed | Biosynthesis of alkyl lysophosphatidic acid by diacylglycerol kinases. | 1.08e-04 | 5 | 115 | 2 | 22627129 | |
| Pubmed | Pharmacokinetics of mycophenolate mofetil and its glucuronide metabolites in healthy volunteers. | 1.08e-04 | 5 | 115 | 2 | 18597651 | |
| Pubmed | 1.08e-04 | 5 | 115 | 2 | 17072959 | ||
| Pubmed | 1.08e-04 | 5 | 115 | 2 | 18556656 | ||
| Pubmed | Analysis of inherited genetic variations at the UGT1 locus in the French-Canadian population. | 1.61e-04 | 6 | 115 | 2 | 19204906 | |
| Cytoband | 2q37 | 1.08e-06 | 31 | 114 | 4 | 2q37 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q37 | 2.28e-05 | 226 | 114 | 6 | chr2q37 | |
| Cytoband | 17p13.2 | 3.56e-04 | 55 | 114 | 3 | 17p13.2 | |
| GeneFamily | EF-hand domain containing|Diacylglycerol kinases | 3.78e-08 | 10 | 68 | 4 | 1178 | |
| GeneFamily | UDP glucuronosyltransferases | 6.08e-06 | 32 | 68 | 4 | 363 | |
| GeneFamily | Small G protein signaling modulators | 4.17e-05 | 3 | 68 | 2 | 751 | |
| GeneFamily | Fibronectin type III domain containing | 3.39e-04 | 160 | 68 | 5 | 555 | |
| GeneFamily | ATPases Ca2+ transporting | 4.93e-04 | 9 | 68 | 2 | 1209 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 3.17e-03 | 161 | 68 | 4 | 593 | |
| GeneFamily | Sterile alpha motif domain containing | 4.44e-03 | 88 | 68 | 3 | 760 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HENDO | JCAD STARD8 PGGHG SRARP GAS6 SHC1 GRN ACE HDAC7 SHROOM4 THBD SHROOM1 FRMD6 NQO1 CCT8L1P | 5.20e-06 | 888 | 111 | 15 | M39049 |
| Coexpression | LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_LARGE_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_DN | STARD8 UPK3B GAS6 ACOT1 ACE HDAC7 SHROOM4 CDKL5 THBD NIPA1 BANK1 | 7.83e-06 | 491 | 111 | 11 | MM455 |
| ToppCell | Basal_cells-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 3.65e-08 | 191 | 115 | 8 | a98915bad9a4a61dd4cbca798914849b805f4a19 | |
| ToppCell | Basal_cells-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 3.02e-07 | 170 | 115 | 7 | 776d4224a682b6c648041827efd69794f88906f0 | |
| ToppCell | AT1-AT2_cells-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 3.67e-07 | 175 | 115 | 7 | 9a95ab5c361ebaa8747983c5a0d69025682a19ad | |
| ToppCell | AT1_cells-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 5.75e-07 | 187 | 115 | 7 | f1dda349335e08dbfc8395d373924037f5ad2fd6 | |
| ToppCell | facs-Lung-nan-3m-Endothelial-endothelial_cell_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.35e-07 | 194 | 115 | 7 | f159ef8541d75a4e98468947f231bb463bec922c | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.15e-07 | 197 | 115 | 7 | a312d9cf4ced949307eb9620be4eed926300b892 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.72e-07 | 199 | 115 | 7 | 0602e2b2aa56d106da63bd342a38bef437b4d496 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Mucous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.02e-07 | 200 | 115 | 7 | ed093626a9cac7531a2bf02f6e345c5e84b8c060 | |
| ToppCell | Club_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 2.49e-06 | 149 | 115 | 6 | 81c813588bb5efb7b31141a75d387210dcb76094 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.90e-06 | 161 | 115 | 6 | 7c9d4410d7142a5f3a05418c994f69978c9ffa17 | |
| ToppCell | AT1_cells-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 4.04e-06 | 162 | 115 | 6 | ae2ba4f21f6f6c512006fa531d670b88be7c04c9 | |
| ToppCell | E15.5-Endothelial-lymphatic_endothelial_cell-endothelial_cell_of_lymphatic_vessel|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.49e-06 | 165 | 115 | 6 | 8d3d5860a4785c4908160ae5fcb421ee80bd78ce | |
| ToppCell | E15.5-Endothelial-lymphatic_endothelial_cell|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.49e-06 | 165 | 115 | 6 | 17ee6f269ed8d378465cf00ca59d48d8b106808e | |
| ToppCell | AT1-AT2_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 5.70e-06 | 172 | 115 | 6 | 0be41df5d35d818deb7316ac21c9366eb4b7bfd1 | |
| ToppCell | Club_cells-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 6.50e-06 | 176 | 115 | 6 | 88c4ed0ab4a4ede8cad21385d799b723b5786cd9 | |
| ToppCell | BAL-Mild-cDC_4|Mild / Compartment, Disease Groups and Clusters | 7.16e-06 | 179 | 115 | 6 | 68511e87b12b8253de7771e5ccfc5869248b8450 | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.16e-06 | 179 | 115 | 6 | 859cd8ee414ad6207c046ada2e655e49322dd01c | |
| ToppCell | AT1_cells-Donor_08|World / lung cells shred on cell class, cell subclass, sample id | 7.40e-06 | 180 | 115 | 6 | 2d52cb5f77dde0e3dccac1333d4ec67ec680fcb2 | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular-Goblet|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.40e-06 | 180 | 115 | 6 | 3dc80bc636bf0e6ffc9762853132a9fe59fd1f66 | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular-Goblet-Goblet|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.40e-06 | 180 | 115 | 6 | 668a2d8e1d5a390309d5eb62c836f5903144bea9 | |
| ToppCell | 3'-Airway_Nasal_SMG-Epithelial-Epithelial_transtional-secretory-SMG_mucus_secreting_cell-SMG_mucous-SMG_mucous_L.0.6.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.88e-06 | 182 | 115 | 6 | 6d7ba2e1f33aaa499a898ed9587197c0ee625e9a | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-papillary_tips_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.88e-06 | 182 | 115 | 6 | 678eadd57e7e830fc2bf9fd35616d3badce01705 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-papillary_tips_cell-Papillary_Tip_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.88e-06 | 182 | 115 | 6 | 8d1229fa5aa6e2e38f2ac6fe4f4dc89752fe9344 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.38e-06 | 184 | 115 | 6 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-I_(AT1)|343B / Donor, Lineage, Cell class and subclass (all cells) | 8.38e-06 | 184 | 115 | 6 | cb15d6bae52c5ec251c2235859dc7e65f630ae23 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.38e-06 | 184 | 115 | 6 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.38e-06 | 184 | 115 | 6 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | 343B-Epithelial_cells-Epithelial-I_(AT1)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 8.38e-06 | 184 | 115 | 6 | bde4eaabd3e9bdaed23867d23a919b9d84b52d4b | |
| ToppCell | pdx-Tumor_cells-T5|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 9.19e-06 | 187 | 115 | 6 | 7e376831a11ee72ed87abcdac631ca46ae29c250 | |
| ToppCell | 5'-Adult-LymphNode-Endothelial-blood_vessel_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.01e-05 | 190 | 115 | 6 | 141266bf411ea675fbf889b20c1b08673c45ff95 | |
| ToppCell | facs-Pancreas-Exocrine-3m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-05 | 193 | 115 | 6 | c3161a14a40323a58aa202c8a1d6ea0e9c2b9814 | |
| ToppCell | 10x5'-lymph-node_spleen-Myeloid_Dendritic|lymph-node_spleen / Manually curated celltypes from each tissue | 1.13e-05 | 194 | 115 | 6 | e2d9186a7e8d1a4a71d7bd6dba7fc955d55479e6 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.17e-05 | 195 | 115 | 6 | 4658fb197657d7692ee344ae76b11b0210c418ba | |
| ToppCell | 356C-Epithelial_cells-Epithelial-I_(AT1)|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.17e-05 | 195 | 115 | 6 | 07a3ef6b0f1201fe2bcb9ea426b8f7a69beb4904 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-I_(AT1)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.17e-05 | 195 | 115 | 6 | b65511770ed67f7447847e2187555b362988af45 | |
| ToppCell | (7)_Epithelial-I_(AT1)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.20e-05 | 196 | 115 | 6 | 150554fa06868d29b0608189862eef6505ba757f | |
| ToppCell | 3'-Distal_airway-Endothelial|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.24e-05 | 197 | 115 | 6 | 9ffb823c0f3f23cc85f9fd3ca24f77817e90bd86 | |
| ToppCell | Basal_cells|World / lung cells shred on cell class, cell subclass, sample id | 1.24e-05 | 197 | 115 | 6 | 24360b660000bdfb999d58fbf4e29585a97e1785 | |
| ToppCell | 3'-Distal_airway-Endothelial-Blood_vessel_EC-capillary_endothelial_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.24e-05 | 197 | 115 | 6 | 6ac8d3e3f573e3848ab33e4df66dfaf8f948ea6c | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.24e-05 | 197 | 115 | 6 | 9244f087ba4b60fdc81d54ce91860de715b3e12c | |
| ToppCell | 3'-Distal_airway-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_general_capillary|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.24e-05 | 197 | 115 | 6 | e3be7758a92f12e0a423394822957e1b7f995110 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_mature|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.27e-05 | 198 | 115 | 6 | 218f33e068eb126458ec33176de3cfa6fc06ddf0 | |
| ToppCell | 3'-Distal_airway-Endothelial-Blood_vessel_EC|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.27e-05 | 198 | 115 | 6 | 3aae7d146ebbb34da3239041a7c0334abff2597f | |
| ToppCell | Epithelial_cells-Basal_cells|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id | 1.27e-05 | 198 | 115 | 6 | 4235005c49fc2b29ad3a0ee6b608f0109d04f775 | |
| ToppCell | wk_20-22-Endothelial-Blood_vessel_endothelial-intermediate_cap|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.27e-05 | 198 | 115 | 6 | a75499f8f1630359b64717c300621aa3b1ab44d4 | |
| ToppCell | Bronchial_Biopsy|World / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.27e-05 | 198 | 115 | 6 | f5b7013045b61fc56894f80092f799770dde1c8f | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.27e-05 | 198 | 115 | 6 | 7cddd474416651088a4e08edfc0ac420ff10a5fe | |
| ToppCell | Frontal_cortex-Neuronal|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.31e-05 | 199 | 115 | 6 | f88039d862f3bfa01dc39d2de4f3f548dc5a0e61 | |
| ToppCell | medial-Endothelial-Capillary|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.35e-05 | 200 | 115 | 6 | fd4dcdc67db2a5dbdd54bd2ae975c66df904d4d8 | |
| ToppCell | medial-2-Endothelial-Capillary|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.35e-05 | 200 | 115 | 6 | e4f390dfd4dd25600f0f7a17c5523283a5966e92 | |
| ToppCell | medial-Endothelial-Capillary-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.35e-05 | 200 | 115 | 6 | 4291b5453e98e20ec8150a96ccc865a5964bc645 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_submucosal-gland|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.35e-05 | 200 | 115 | 6 | 85c0f038bcfb42669dca2b80273b0f8a1421405e | |
| ToppCell | COVID_vent-Lymphocytic-T_cell-Gamma_Delta_T_cell|COVID_vent / Disease condition, Lineage, Cell class and subclass | 2.39e-05 | 132 | 115 | 5 | dbc0a332fd8f63ebdcf9716e45d7f46f26509349 | |
| ToppCell | LPS-IL1RA-Endothelial-Epi-like-Alv_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.96e-05 | 138 | 115 | 5 | 5f8ac8f67e34a7cf560099208e6884102532391e | |
| ToppCell | primary_visual_cortex|World / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.28e-05 | 141 | 115 | 5 | 605d7b28e99c943f64b4095855a6f9f70e92cb09 | |
| ToppCell | BAL-Mild-Myeloid-cDC-cDC-cDC_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.26e-05 | 149 | 115 | 5 | a85a051e0d82430160967e72fa04b55f43e84513 | |
| ToppCell | BAL-Mild-Myeloid-cDC-cDC-cDC_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.40e-05 | 150 | 115 | 5 | 7a381f5ae94eba5eb60dcbf83416b4eb18c279ea | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.98e-05 | 160 | 115 | 5 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Type_1_alveolar|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 5.98e-05 | 160 | 115 | 5 | 58ed3a074932ccc951e07868dfdc61b99ae1cc2b | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.98e-05 | 160 | 115 | 5 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | AT1-AT2_cells-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 6.34e-05 | 162 | 115 | 5 | 57d627259d27f39885bf416d74bcb6656db6e27b | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Myeloid-Granulocytic-Neutrophil-Neu_c2-CXCR4(low)|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.67e-05 | 84 | 115 | 4 | 9ffce86c3491a464fbec9b9e5e6e7b7cc28afa88 | |
| ToppCell | LPS-IL1RA+antiTNF-Lymphocytic_B-B_cells-B-cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.53e-05 | 168 | 115 | 5 | eeb381b62c7ba263af96de1194ed59e57b6ca3ae | |
| ToppCell | LPS-IL1RA+antiTNF-Lymphocytic_B-B_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.53e-05 | 168 | 115 | 5 | 063d0368d656962b335154c230bdcd9236e7c9ad | |
| ToppCell | LPS-IL1RA+antiTNF-Lymphocytic_B|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.53e-05 | 168 | 115 | 5 | a7c4251d8a83bc30196a444028a35c17c24dc291 | |
| ToppCell | droplet-Pancreas-Exocrine-18m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.75e-05 | 169 | 115 | 5 | 53690d6f9712b54aa99a0408aae930d64ae478e5 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Basal_1|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 7.97e-05 | 170 | 115 | 5 | aabe993c9f337b1caaeb0e64626a3920579c41b7 | |
| ToppCell | droplet-Lung-nan-18m-Epithelial-Club_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.19e-05 | 171 | 115 | 5 | 3b02dc5609f5bcd055b532bb4631d2a7183804e9 | |
| ToppCell | droplet-Lung-nan-18m-Epithelial-club_cell_of_bronchiole|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.19e-05 | 171 | 115 | 5 | 88309bfb1cf427783c853dfd6709cd5edc9074b9 | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Monocytic-Macrophage-IM|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.42e-05 | 172 | 115 | 5 | c96bd3407911df3e3e6d7a3dba786b11814b9598 | |
| ToppCell | PND07-28-samps-Myeloid-Macrophage-CD163+_Macrophage|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 8.42e-05 | 172 | 115 | 5 | 9a659442dc41bd2a4361a7e38a7ee37a39781667 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Basal_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 8.42e-05 | 172 | 115 | 5 | b66dbfff5e4f53ca8ece91ff9c5dc66a71f07c63 | |
| ToppCell | droplet-Lung-18m-Epithelial-airway_epithelial-club_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.89e-05 | 174 | 115 | 5 | 46838b4bb9b4d8ce5e1c608a700e7f393bc52658 | |
| ToppCell | droplet-Lung-18m-Epithelial-airway_epithelial-club_cell-club_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.89e-05 | 174 | 115 | 5 | 103594eeb600eb5bc9cbf09a65b286b3a3a18cdc | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.89e-05 | 174 | 115 | 5 | 4da79da7a09ee1e345102c5331675ebcdbe56171 | |
| ToppCell | AT1-AT2_cells-Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 9.13e-05 | 175 | 115 | 5 | bdd85ba280648a0283c1984662a34c7b840f64dd | |
| ToppCell | (03)_Secretory-(4)_1wkpi|(03)_Secretory / shred by cell type and Timepoint | 9.13e-05 | 175 | 115 | 5 | 06b52f85baa31b55bb31477244892b6da79fe2c9 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Calb1-Excitatory_Neuron.Sc17a7.Calb1-Lpl_(Layer_2/3)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 9.51e-05 | 92 | 115 | 4 | dfe63bb979f0382163955b32909ffab1de37685a | |
| ToppCell | LPS_only-Lymphocytic_B-B_cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.63e-05 | 177 | 115 | 5 | c82332c5f656aa26513e4f7525d5d4d733019725 | |
| ToppCell | LPS_only-Lymphocytic_B|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.63e-05 | 177 | 115 | 5 | 5ed65e08d773d157840317c72e0d43c261d438d4 | |
| ToppCell | LPS_only-Lymphocytic_B-B_cells-B-cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.63e-05 | 177 | 115 | 5 | 8a955a7ab84c434f9ad4b467246b8be3cb479406 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.02e-04 | 179 | 115 | 5 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | AT1_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 1.02e-04 | 179 | 115 | 5 | 1603117b52623663458a977c94bf7f9f6c1114b8 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.04e-04 | 180 | 115 | 5 | f2f6e83127a4a415e65c76a35efa8175fbd5b5d9 | |
| ToppCell | facs-Marrow-B-cells-18m-Hematologic-MPP_Fraction_B_+_C|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-04 | 180 | 115 | 5 | 7368ab31c3273374ef260f0d710d4eea83cbc4a2 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-Pecam____fenestrated_capillary_endothelial|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-04 | 180 | 115 | 5 | 79c5725f02e038d0187f4a1e1591f2492538aa57 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.07e-04 | 181 | 115 | 5 | 330d4322f4c4373f706273c1f4e218b59051b7fd | |
| ToppCell | COVID-19-Endothelial_cells-Capillary_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 1.07e-04 | 181 | 115 | 5 | c5f9c92af1384d9089c65afdf41c6feb8345a3ae | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.07e-04 | 181 | 115 | 5 | 3f4d5d79c1286614514b0e8134079d6128a2a23e | |
| ToppCell | AT1-AT2_cells-Donor_05|World / lung cells shred on cell class, cell subclass, sample id | 1.07e-04 | 181 | 115 | 5 | ca23ce4f2c7b684d8ddd0e8619b3b696023d75e3 | |
| ToppCell | Club-club-8|World / Class top | 1.10e-04 | 182 | 115 | 5 | 8111d917e588008d947021460ddf8f1e7ae1337a | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.13e-04 | 183 | 115 | 5 | ce8be9418b473ea94ec806edc7a2078cc30c1703 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial-Tuft-related|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.13e-04 | 183 | 115 | 5 | 263937906ddabc798bbe60f0da28ba859a5c72e2 | |
| ToppCell | AT1-AT2_cells-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 1.13e-04 | 183 | 115 | 5 | 6821dca076318115d360ff426eb1218cfe104063 | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Endothelial-blood_vessel_EC-venous_capillary|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.16e-04 | 184 | 115 | 5 | 97e97de52daaff8840f4ee76a94ba5e3f79de7ce | |
| ToppCell | facs-Pancreas-Exocrine-18m-Epithelial-pancreatic_ductal_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-04 | 184 | 115 | 5 | 10706441e7695212f95689414f31e8082b5eaf0a | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell-Goblet_(bronchial)-Goblet_(bronchial)_L.0.4.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.16e-04 | 184 | 115 | 5 | 01c19a830348ab0b9c02c1546a439de70ee10f97 | |
| ToppCell | facs-Pancreas-Exocrine-18m-Epithelial-pancreatic_ductal_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-04 | 184 | 115 | 5 | 4bb0976a75126ad2b3deb5d2229f0716fafe200e | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Neuro-endocrine/ionocytic-lung_neuroendocrine_cell-Neuroendocrine|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.19e-04 | 185 | 115 | 5 | b52e6adfecac93210c27c1d321a5951d54846c40 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Activated_Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.19e-04 | 185 | 115 | 5 | 808d5e880069aff8866cd2c733b9fe568a37701f | |
| Computational | Genes in the cancer module 70. | 9.82e-05 | 43 | 61 | 4 | MODULE_70 | |
| Drug | naringenin chalcone | 2.30e-09 | 5 | 107 | 4 | ctd:C027329 | |
| Drug | anthrarobin | 2.30e-09 | 5 | 107 | 4 | ctd:C032186 | |
| Drug | erucin | 3.24e-09 | 28 | 107 | 6 | CID000078160 | |
| Drug | sulforaphane nitrile | 6.03e-09 | 15 | 107 | 5 | CID000543743 | |
| Drug | 1,2,5,8-tetrahydroxy anthraquinone | 6.87e-09 | 6 | 107 | 4 | ctd:C543211 | |
| Drug | alloin | 6.87e-09 | 6 | 107 | 4 | ctd:C006457 | |
| Drug | 2',5'-dihydroxychalcone | 6.87e-09 | 6 | 107 | 4 | ctd:C107497 | |
| Drug | quercetin-3,4'-diglucoside | 8.74e-09 | 16 | 107 | 5 | CID005320835 | |
| Drug | 2',4'-dihydroxychalcone | 1.60e-08 | 7 | 107 | 4 | ctd:C059354 | |
| Drug | glucoraphanin | 1.62e-08 | 36 | 107 | 6 | CID000656556 | |
| Drug | 1,4-dihydroxyanthraquinone | 3.18e-08 | 8 | 107 | 4 | ctd:C034890 | |
| Drug | plumbagin | 5.15e-08 | 22 | 107 | 5 | ctd:C014758 | |
| Drug | AC1MRQNQ | 5.70e-08 | 9 | 107 | 4 | CID003522271 | |
| Drug | DHPASiU | 5.70e-08 | 9 | 107 | 4 | CID000197602 | |
| Drug | 3-iodophenol | 5.70e-08 | 9 | 107 | 4 | CID000012272 | |
| Drug | AC1L4J7U | 5.70e-08 | 9 | 107 | 4 | CID000186631 | |
| Drug | Chebi:32663 | 5.70e-08 | 9 | 107 | 4 | CID005460873 | |
| Drug | 2,6-dihydroxyanthraquinone | 9.47e-08 | 10 | 107 | 4 | ctd:C034889 | |
| Drug | 5,6-benzoquinoline | 1.03e-07 | 25 | 107 | 5 | CID000006796 | |
| Drug | AC1L1G0K | 1.11e-07 | 49 | 107 | 6 | CID000003473 | |
| Drug | 4-nitrophenyl)imidazole | 1.48e-07 | 11 | 107 | 4 | CID000123155 | |
| Drug | AC1O5XMV | 1.48e-07 | 11 | 107 | 4 | CID006442661 | |
| Drug | licochalcone A | 1.55e-07 | 27 | 107 | 5 | ctd:C070840 | |
| Drug | N-OH-DABZ | 2.22e-07 | 12 | 107 | 4 | CID000051366 | |
| Drug | 1-O-beta-D-glucopyranosyl-D-mannitol | 2.22e-07 | 12 | 107 | 4 | CID000088735 | |
| Drug | 4-hydroxyestrone | 2.22e-07 | 12 | 107 | 4 | ctd:C026418 | |
| Drug | 2,4,6-TCB | 2.22e-07 | 12 | 107 | 4 | CID000037247 | |
| Drug | nonanoyl-N-methylglucamide | 2.22e-07 | 12 | 107 | 4 | CID000160090 | |
| Drug | 7,7,7-triphenylheptanoic acid | 2.22e-07 | 12 | 107 | 4 | CID000276709 | |
| Drug | iberin | 2.26e-07 | 29 | 107 | 5 | CID000010455 | |
| Drug | 2-hydroxyestrone | 3.19e-07 | 13 | 107 | 4 | ctd:C024980 | |
| Drug | tritanol | 3.19e-07 | 13 | 107 | 4 | CID000006457 | |
| Drug | 5-azido-UDP-glucuronic acid | 3.19e-07 | 13 | 107 | 4 | CID003081279 | |
| Drug | cotinine-N-glucuronide | 3.19e-07 | 13 | 107 | 4 | CID000000411 | |
| Drug | alizarin | 3.19e-07 | 13 | 107 | 4 | ctd:C010078 | |
| Drug | TBHQ | 3.45e-07 | 141 | 107 | 8 | CID000016043 | |
| Drug | Muracein C | 3.80e-07 | 32 | 107 | 5 | CID003086323 | |
| Drug | indole-2-carboxylic acid | 3.80e-07 | 32 | 107 | 5 | CID000072899 | |
| Drug | hydratropic acid | 4.02e-07 | 4 | 107 | 3 | ctd:C013025 | |
| Drug | 2-vanillin | 4.02e-07 | 4 | 107 | 3 | ctd:C060843 | |
| Drug | diphenylacetic acid | 4.02e-07 | 4 | 107 | 3 | ctd:C037760 | |
| Drug | propranolol glucuronide | 4.45e-07 | 14 | 107 | 4 | CID000119515 | |
| Drug | PCB-61 | 4.45e-07 | 14 | 107 | 4 | CID000036401 | |
| Drug | BP-3,6-quinol | 4.46e-07 | 33 | 107 | 5 | CID000119292 | |
| Drug | ketoprofen | 5.62e-07 | 64 | 107 | 6 | CID000003825 | |
| Drug | AC1L4Q08 | 6.05e-07 | 15 | 107 | 4 | CID000161747 | |
| Drug | 2,2',3,5,5'-pentachlorobiphenyl | 6.05e-07 | 15 | 107 | 4 | CID000040469 | |
| Drug | afloqualone | 6.05e-07 | 15 | 107 | 4 | CID000002040 | |
| Drug | naphthyl sulphate | 6.05e-07 | 15 | 107 | 4 | CID000114775 | |
| Drug | coumarin-3-carboxylic acid | 6.05e-07 | 15 | 107 | 4 | CID000010752 | |
| Drug | bergamottin | 6.05e-07 | 15 | 107 | 4 | ctd:C068337 | |
| Drug | AC1L9DGV | 7.00e-07 | 36 | 107 | 5 | CID000417381 | |
| Drug | 1'-hydroxyestragole | 8.03e-07 | 16 | 107 | 4 | CID000040003 | |
| Drug | bilirubin-phosphate | 8.03e-07 | 16 | 107 | 4 | CID005497144 | |
| Drug | Meldola | 8.08e-07 | 68 | 107 | 6 | CID000081507 | |
| Drug | x Me | 9.26e-07 | 38 | 107 | 5 | CID009600424 | |
| Drug | isovaleric acid | 1.00e-06 | 5 | 107 | 3 | ctd:C008216 | |
| Drug | biphenylylacetic acid | 1.00e-06 | 5 | 107 | 3 | ctd:C012776 | |
| Drug | 3 beta,5 alpha,25R)- 3-hydroxyspirostan-12-one | 1.05e-06 | 17 | 107 | 4 | CID000003573 | |
| Drug | 6-hydroxychrysene | 1.05e-06 | 17 | 107 | 4 | CID000037766 | |
| Drug | Tranilast sodium | 1.20e-06 | 115 | 107 | 7 | CID000005527 | |
| Drug | thymoquinone | 1.20e-06 | 40 | 107 | 5 | CID000010281 | |
| Drug | SureCN12722713 | 1.34e-06 | 18 | 107 | 4 | CID005488034 | |
| Drug | ethyl-beta-D-6-glucosiduronic acid | 1.34e-06 | 18 | 107 | 4 | CID000152226 | |
| Drug | Br 2 | 1.34e-06 | 18 | 107 | 4 | CID003060900 | |
| Drug | 2,3,7-trichlorodibenzo-p-dioxin | 1.34e-06 | 18 | 107 | 4 | CID000036614 | |
| Drug | ApApG | 1.34e-06 | 18 | 107 | 4 | CID003081975 | |
| Drug | C1 11-32 | 1.34e-06 | 18 | 107 | 4 | CID000443077 | |
| Drug | C11131 | 1.34e-06 | 18 | 107 | 4 | CID000443076 | |
| Drug | AC1NFJIQ | 1.55e-06 | 42 | 107 | 5 | CID004659568 | |
| Drug | 9-OH-risperidone | 1.69e-06 | 19 | 107 | 4 | CID000475100 | |
| Drug | 5alpha-spirostan-3beta-ol | 1.69e-06 | 19 | 107 | 4 | CID000091433 | |
| Drug | almokalant | 1.69e-06 | 19 | 107 | 4 | CID003033962 | |
| Drug | 7,8-benzoquinoline | 1.74e-06 | 43 | 107 | 5 | CID000009191 | |
| Drug | 3-phenylpropionic acid | 2.00e-06 | 6 | 107 | 3 | ctd:C035253 | |
| Drug | Indoprofen | 2.00e-06 | 6 | 107 | 3 | ctd:D007216 | |
| Drug | tectochrysin | 2.11e-06 | 20 | 107 | 4 | CID005281954 | |
| Drug | AC1L1OBF | 2.11e-06 | 20 | 107 | 4 | CID000032736 | |
| Drug | 4'-hydroxydiclofenac | 2.11e-06 | 20 | 107 | 4 | CID000116545 | |
| Drug | entacapone | 2.11e-06 | 20 | 107 | 4 | ctd:C071192 | |
| Drug | acridine | 2.28e-06 | 81 | 107 | 6 | CID000009215 | |
| Drug | estriol-16-glucuronide | 2.59e-06 | 21 | 107 | 4 | CID000122281 | |
| Drug | dulcin | 2.59e-06 | 21 | 107 | 4 | CID000009013 | |
| Drug | Benzamidoxime hydrochloride | 2.59e-06 | 21 | 107 | 4 | CID000069186 | |
| Drug | 1-hydroxypyrene | 3.04e-06 | 48 | 107 | 5 | CID000021387 | |
| Drug | sulforaphane | 3.14e-06 | 189 | 107 | 8 | CID000005350 | |
| Drug | amonafide | 3.16e-06 | 22 | 107 | 4 | CID000050515 | |
| Drug | N-methylpiperazine | 3.16e-06 | 22 | 107 | 4 | CID000053167 | |
| Drug | nogalonic acid methyl ester | 3.47e-06 | 87 | 107 | 6 | CID000443820 | |
| Drug | phenanthroline | 3.74e-06 | 50 | 107 | 5 | CID000067473 | |
| Drug | amidoxime | 3.81e-06 | 23 | 107 | 4 | CID000465967 | |
| Drug | estradiol-3-glucuronide | 3.81e-06 | 23 | 107 | 4 | CID000066651 | |
| Drug | phenanthridine | 3.81e-06 | 23 | 107 | 4 | CID000009189 | |
| Drug | Finasteride [98319-26-7]; Down 200; 10.8uM; HL60; HT_HG-U133A | 3.81e-06 | 194 | 107 | 8 | 2206_DN | |
| Drug | C2-MPAcid | 4.13e-06 | 51 | 107 | 5 | CID000508230 | |
| Drug | diradylglycerol | 4.13e-06 | 51 | 107 | 5 | CID006437874 | |
| Drug | 8-prenylnaringenin | 4.55e-06 | 52 | 107 | 5 | CID000480764 | |
| Drug | AC1NQGK1 | 4.55e-06 | 52 | 107 | 5 | CID005195977 | |
| Drug | AS-3201 | 4.56e-06 | 24 | 107 | 4 | CID000153948 | |
| Drug | butylated hydroxytoluene | 5.14e-06 | 143 | 107 | 7 | CID000031404 | |
| Disease | X-21448 measurement | 1.49e-10 | 10 | 108 | 5 | EFO_0800816 | |
| Disease | N-acetyl-4-chlorophenylalanine measurement | 8.46e-10 | 5 | 108 | 4 | EFO_0801060 | |
| Disease | 5-hydroxyindole sulfate measurement | 8.46e-10 | 5 | 108 | 4 | EFO_0800085 | |
| Disease | nuclear receptor subfamily 1 group D member 2 measurement | 8.46e-10 | 5 | 108 | 4 | EFO_0801853 | |
| Disease | X-21339 measurement | 5.89e-09 | 7 | 108 | 4 | EFO_0800808 | |
| Disease | X-11793--oxidized bilirubin measurement | 1.17e-08 | 8 | 108 | 4 | EFO_0021260 | |
| Disease | Succinimide measurement | 1.17e-08 | 8 | 108 | 4 | EFO_0022118 | |
| Disease | X-11530 measurement | 1.17e-08 | 8 | 108 | 4 | EFO_0021249 | |
| Disease | sulfate of piperine metabolite C16H19NO3 (2) measurement | 1.17e-08 | 8 | 108 | 4 | EFO_0801034 | |
| Disease | cholelithiasis, bilirubin measurement | 1.17e-08 | 8 | 108 | 4 | EFO_0004570, EFO_0004799 | |
| Disease | X-11522 measurement | 1.17e-08 | 8 | 108 | 4 | EFO_0800696 | |
| Disease | X-10458 measurement | 1.17e-08 | 8 | 108 | 4 | EFO_0800692 | |
| Disease | X-24849 measurement | 1.17e-08 | 8 | 108 | 4 | EFO_0800909 | |
| Disease | serum N-desmethylclozapine measurement | 1.17e-08 | 8 | 108 | 4 | EFO_0600043 | |
| Disease | plasma clozapine measurement | 1.17e-08 | 8 | 108 | 4 | EFO_0600038 | |
| Disease | membrane-associated progesterone receptor component 1 measurement | 1.17e-08 | 8 | 108 | 4 | EFO_0802740 | |
| Disease | X-16946 measurement | 1.17e-08 | 8 | 108 | 4 | EFO_0800766 | |
| Disease | X-11442 measurement | 2.11e-08 | 9 | 108 | 4 | EFO_0021236 | |
| Disease | X-11441 measurement | 2.11e-08 | 9 | 108 | 4 | EFO_0021235 | |
| Disease | circulating cell free DNA measurement | 2.11e-08 | 9 | 108 | 4 | EFO_0004739 | |
| Disease | sulfate of piperine metabolite C18H21NO3 (3) measurement | 2.11e-08 | 9 | 108 | 4 | EFO_0801037 | |
| Disease | sulfate of piperine metabolite C18H21NO3 (1) measurement | 2.11e-08 | 9 | 108 | 4 | EFO_0801036 | |
| Disease | X-11880 measurement | 2.11e-08 | 9 | 108 | 4 | EFO_0800698 | |
| Disease | protein-tyrosine kinase 6 measurement | 2.11e-08 | 9 | 108 | 4 | EFO_0020691 | |
| Disease | testis-specific chromodomain protein Y 1 measurement | 2.11e-08 | 9 | 108 | 4 | EFO_0802127 | |
| Disease | bilirubin measurement, response to xenobiotic stimulus | 2.11e-08 | 9 | 108 | 4 | EFO_0004570, GO_0009410 | |
| Disease | bilirubin measurement, response to tenofovir | 3.50e-08 | 10 | 108 | 4 | EFO_0004570, EFO_0009279 | |
| Disease | UDP-glucuronosyltransferase 1-6 measurement | 3.50e-08 | 10 | 108 | 4 | EFO_0802185 | |
| Disease | X-23974 measurement | 3.50e-08 | 10 | 108 | 4 | EFO_0800867 | |
| Disease | indole-3-carboxylate measurement | 4.77e-08 | 3 | 108 | 3 | EFO_0800043 | |
| Disease | blood 4-oxo-retinoic acid measurement | 4.77e-08 | 3 | 108 | 3 | EFO_0022216 | |
| Disease | pregnenetriol sulfate measurement | 5.49e-08 | 11 | 108 | 4 | EFO_0800586 | |
| Disease | plasma N-desmethylclozapine measurement | 5.49e-08 | 11 | 108 | 4 | EFO_0600039 | |
| Disease | histidine betaine (hercynine) measurement | 5.49e-08 | 11 | 108 | 4 | EFO_0800972 | |
| Disease | X-21796 measurement | 5.49e-08 | 11 | 108 | 4 | EFO_0800825 | |
| Disease | insomnia, bilirubin measurement | 5.49e-08 | 11 | 108 | 4 | EFO_0004570, EFO_0004698 | |
| Disease | aldosterone measurement | 5.49e-08 | 11 | 108 | 4 | EFO_0010219 | |
| Disease | p-cresol glucuronide measurement | 8.21e-08 | 12 | 108 | 4 | EFO_0800079 | |
| Disease | biliverdin measurement | 8.21e-08 | 12 | 108 | 4 | EFO_0021033 | |
| Disease | pregnenetriol disulfate measurement | 1.18e-07 | 13 | 108 | 4 | EFO_0800587 | |
| Disease | retinol dehydrogenase 16 measurement | 1.18e-07 | 13 | 108 | 4 | EFO_0802007 | |
| Disease | low density lipoprotein cholesterol measurement, body fat percentage | 3.89e-07 | 17 | 108 | 4 | EFO_0004611, EFO_0007800 | |
| Disease | X-21441 measurement | 3.89e-07 | 17 | 108 | 4 | EFO_0800814 | |
| Disease | angiopoietin-related protein 1 measurement | 4.99e-07 | 18 | 108 | 4 | EFO_0801382 | |
| Disease | 3-carboxy-4-methyl-5-pentyl-2-furanpropionate (3-CMPFP) measurement | 9.46e-07 | 6 | 108 | 3 | EFO_0800566 | |
| Disease | tissue factor measurement | 9.68e-07 | 21 | 108 | 4 | EFO_0010623 | |
| Disease | neuroblastoma, cutaneous melanoma | 3.25e-06 | 28 | 108 | 4 | EFO_0000389, EFO_0000621 | |
| Disease | xanthurenate measurement | 3.76e-06 | 29 | 108 | 4 | EFO_0010551 | |
| Disease | response to dolutegravir | 4.32e-06 | 30 | 108 | 4 | EFO_0600017 | |
| Disease | indoleacetate measurement | 5.62e-06 | 10 | 108 | 3 | EFO_0021015 | |
| Disease | vitamin D deficiency | 1.02e-05 | 37 | 108 | 4 | EFO_0003762 | |
| Disease | X-24588 measurement | 1.33e-05 | 13 | 108 | 3 | EFO_0800898 | |
| Disease | hormone measurement | 1.47e-05 | 84 | 108 | 5 | EFO_0004730 | |
| Disease | vitamin D measurement, COVID-19 | 3.17e-05 | 49 | 108 | 4 | EFO_0004631, MONDO_0100096 | |
| Disease | urate measurement, spine bone mineral density | 6.18e-05 | 58 | 108 | 4 | EFO_0004531, EFO_0007701 | |
| Disease | Interstitial lung disease 2 | 7.93e-05 | 4 | 108 | 2 | cv:C5561926 | |
| Disease | INTERSTITIAL LUNG DISEASE 2 | 7.93e-05 | 4 | 108 | 2 | 178500 | |
| Disease | small cell carcinoma (is_implicated_in) | 7.93e-05 | 4 | 108 | 2 | DOID:0050685 (is_implicated_in) | |
| Disease | Hailey-Hailey disease (implicated_via_orthology) | 1.97e-04 | 6 | 108 | 2 | DOID:0050429 (implicated_via_orthology) | |
| Disease | Diffuse interstitial pulmonary fibrosis | 1.97e-04 | 6 | 108 | 2 | cv:C0085786 | |
| Disease | type 2 diabetes mellitus (biomarker_via_orthology) | 2.12e-04 | 147 | 108 | 5 | DOID:9352 (biomarker_via_orthology) | |
| Disease | Cardiomegaly | 2.38e-04 | 82 | 108 | 4 | C0018800 | |
| Disease | Cardiac Hypertrophy | 2.38e-04 | 82 | 108 | 4 | C1383860 | |
| Disease | thyroxine measurement | 2.50e-04 | 83 | 108 | 4 | EFO_0005130 | |
| Disease | cholelithiasis | 3.12e-04 | 88 | 108 | 4 | EFO_0004799 | |
| Disease | Nodular glomerulosclerosis | 4.59e-04 | 41 | 108 | 3 | C0017667 | |
| Disease | idiopathic pulmonary fibrosis (is_implicated_in) | 4.70e-04 | 9 | 108 | 2 | DOID:0050156 (is_implicated_in) | |
| Disease | Diabetic Nephropathy | 5.66e-04 | 44 | 108 | 3 | C0011881 | |
| Disease | Streptozotocin Diabetes | 6.79e-04 | 108 | 108 | 4 | C0038433 | |
| Disease | Diabetes Mellitus, Experimental | 6.79e-04 | 108 | 108 | 4 | C0011853 | |
| Disease | gallstones | 6.79e-04 | 108 | 108 | 4 | EFO_0004210 | |
| Disease | Alloxan Diabetes | 6.79e-04 | 108 | 108 | 4 | C0002152 | |
| Disease | urinary bladder carcinoma | 6.88e-04 | 47 | 108 | 3 | MONDO_0004986 | |
| Disease | Depressive disorder | 6.96e-04 | 289 | 108 | 6 | C0011581 | |
| Disease | glomerulosclerosis (implicated_via_orthology) | 7.14e-04 | 11 | 108 | 2 | DOID:0050851 (implicated_via_orthology) | |
| Disease | pulmonary fibrosis | 7.14e-04 | 11 | 108 | 2 | EFO_0009448 | |
| Disease | chronic kidney disease (implicated_via_orthology) | 8.55e-04 | 12 | 108 | 2 | DOID:784 (implicated_via_orthology) | |
| Disease | dodecanedioate measurement | 8.55e-04 | 12 | 108 | 2 | EFO_0021054 | |
| Disease | leukemia (is_implicated_in) | 1.01e-03 | 13 | 108 | 2 | DOID:1240 (is_implicated_in) | |
| Disease | metabolite measurement | 1.07e-03 | 560 | 108 | 8 | EFO_0004725 | |
| Disease | Hamman-Rich syndrome | 1.17e-03 | 14 | 108 | 2 | C0085786 | |
| Disease | Body Weight | 1.35e-03 | 15 | 108 | 2 | C0005910 | |
| Disease | pulmonary hypertension (is_marker_for) | 1.69e-03 | 64 | 108 | 3 | DOID:6432 (is_marker_for) | |
| Disease | glomerulonephritis (implicated_via_orthology) | 1.74e-03 | 17 | 108 | 2 | DOID:2921 (implicated_via_orthology) | |
| Disease | dermatomyositis (is_marker_for) | 1.74e-03 | 17 | 108 | 2 | DOID:10223 (is_marker_for) | |
| Disease | Coronary Arteriosclerosis | 1.77e-03 | 65 | 108 | 3 | C0010054 | |
| Disease | Coronary Artery Disease | 1.77e-03 | 65 | 108 | 3 | C1956346 | |
| Disease | Bipolar Disorder | 1.89e-03 | 477 | 108 | 7 | C0005586 | |
| Disease | Usual Interstitial Pneumonia | 2.18e-03 | 19 | 108 | 2 | C4721509 | |
| Disease | Hamman-Rich Disease | 2.18e-03 | 19 | 108 | 2 | C4721508 | |
| Disease | anorectal malformation | 2.18e-03 | 19 | 108 | 2 | MONDO_0019938 | |
| Disease | Familial Idiopathic Pulmonary Fibrosis | 2.42e-03 | 20 | 108 | 2 | C4721952 | |
| Disease | Mental Depression | 2.47e-03 | 254 | 108 | 5 | C0011570 | |
| Disease | serum metabolite measurement | AOC1 UGT1A10 UGT1A8 UGT1A7 UGT1A9 ACE EEF1A2 BCO1 PTPRH DGCR8 | 2.48e-03 | 945 | 108 | 10 | EFO_0005653 |
| Disease | ST2 protein measurement | 2.66e-03 | 21 | 108 | 2 | EFO_0010599 | |
| Disease | Idiopathic Pulmonary Fibrosis | 2.66e-03 | 21 | 108 | 2 | C1800706 | |
| Disease | sex interaction measurement, bilirubin measurement | 2.92e-03 | 22 | 108 | 2 | EFO_0004570, EFO_0008343 | |
| Disease | nephrosis (biomarker_via_orthology) | 2.92e-03 | 22 | 108 | 2 | DOID:2527 (biomarker_via_orthology) | |
| Disease | Epilepsy, Cryptogenic | 3.42e-03 | 82 | 108 | 3 | C0086237 | |
| Disease | Awakening Epilepsy | 3.42e-03 | 82 | 108 | 3 | C0751111 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EGQMERSQNWGHPGV | 536 | Q8NDB2 | |
| PIIWGGEPRAHAMAQ | 381 | Q86TX2 | |
| GPVNTWMGLHDQNGP | 206 | P07306 | |
| AWPVAPGMHHEAQQQ | 1111 | Q5SNV9 | |
| MPGPNANWTAGLSVH | 321 | Q9BQT9 | |
| ITPLPAGHMIGGTIW | 146 | Q9P2I0 | |
| LEGPIPAHLLGNMWA | 871 | P12821 | |
| HANMGALGAVNWTPL | 616 | Q8NFD2 | |
| LMVGPHAAVPNLWDN | 151 | P0C2W7 | |
| QKGTCEQGPHQVPWM | 331 | P28799 | |
| PLSQSAPTGLNHMGW | 121 | Q9NR80 | |
| DANENWHGMPGRVEP | 41 | Q8TAB5 | |
| GEPWVQAPGHMIISA | 891 | P52824 | |
| WQTETGGHMLTPLPG | 466 | Q9NR19 | |
| QIHSMADQVLPPGWQ | 596 | P19801 | |
| EPLPDGWIMTFHNSG | 301 | Q8WYQ5 | |
| EVVSHMAGPWGVQPE | 2776 | Q75N90 | |
| WINIIMDGPPAQSLG | 736 | P98194 | |
| WINIIMDGPPAQSLG | 766 | O75185 | |
| GPAVVMNRFSPAHWV | 191 | P55064 | |
| QGPVEPSWENAGHTM | 26 | Q9HC84 | |
| KEAWMEPLQPTVHQG | 521 | C9J798 | |
| PGIHPPTLNQIMDWI | 636 | Q9H8H0 | |
| PIPGTIEMLHPWNNE | 646 | Q14126 | |
| IMDHGPPVNWEDIAG | 391 | Q6PIW4 | |
| PPNMHVWGEALVLDS | 486 | Q14667 | |
| AGLWAATQVSMDHPP | 61 | Q5T9C9 | |
| HLSSPWMQQRAVLGP | 191 | Q96S90 | |
| WNPGMGSLQPGEFDV | 306 | Q8IYA8 | |
| MGRKWSGPTAEHQLP | 1 | Q9H478 | |
| QEPAHGGMQPDGAIW | 461 | Q9P266 | |
| QVSLGLGQPWHAVMD | 516 | Q7Z6M2 | |
| HPWCSGNMVQGKELP | 66 | Q5VYM1 | |
| ELREVHQWMQTGGLP | 1186 | O15055 | |
| HQWMQTGGLPAAIDV | 1191 | O15055 | |
| MTPGNSFAPGHRQLW | 976 | Q92628 | |
| LGEINPQHSWMVAGP | 1136 | Q9C000 | |
| RQAMLGQVHEVPEGW | 1451 | P39060 | |
| EGSNLPVMVWIHGGA | 136 | O00748 | |
| PRSPGWMDFIQHLGV | 21 | Q9H295 | |
| DAPMWLNGTHPALGD | 116 | P55259 | |
| HGNPFNMEVLVDSWP | 36 | Q969I3 | |
| MCGQAGWTPQEHPGL | 501 | H0YKK7 | |
| PGEKTGWLINMHPTE | 56 | Q07864 | |
| PEQPGGPQQEVHMLW | 166 | Q32M88 | |
| EDGVAMPHQWLEGNL | 241 | Q86XP1 | |
| LPPRLDWFVHTQMGQ | 11 | Q96JZ2 | |
| IHGDMNVILWPIQSG | 161 | P15559 | |
| VTWGIDQFGPPMIIH | 96 | Q96NE9 | |
| NPQENRWHTIAPMGT | 481 | Q9Y2M5 | |
| SSIPWQQLQHMPAQG | 1556 | Q9Y6J0 | |
| GPTTMHVQWQPVGGA | 1486 | Q99715 | |
| TNHLAWVPTVMPNGQ | 461 | Q8TF40 | |
| VPISGWHGDNMLEPS | 191 | Q05639 | |
| GPVINHGMWQTISVE | 371 | Q14393 | |
| MGQWQLEVGDPAPLG | 61 | Q9BVM2 | |
| SHNIALGQLPEMPWE | 746 | Q53R41 | |
| ILNIPSMHGGSNLWG | 661 | Q9Y6T7 | |
| SMHPGWADTPGVRQA | 226 | A0PJE2 | |
| WADTPGVRQAMPGFH | 231 | A0PJE2 | |
| HGNPFNMEVLVDSWP | 36 | A0A0U1RQE8 | |
| QMVPAISQNWTFHGP | 221 | Q9NS66 | |
| GIAMPHQWLEGNLPV | 231 | Q16760 | |
| NVNVAWAGGLDPPMG | 756 | Q8WUI4 | |
| SEPGGGQVPKGQHMW | 896 | Q13255 | |
| LQLPGQMDPGWHVSS | 901 | O76039 | |
| NSPWKVHLSNVGPEM | 711 | Q7Z5N4 | |
| IFWIAPAHGPTNIMV | 176 | Q7RTP0 | |
| VTLEMQDGHVLWGPQ | 96 | O75309 | |
| MEWDNGTGQALGLPP | 1 | Q15077 | |
| MTTQQIDLQGPGPWG | 1 | O00151 | |
| NPLHNPWGMELAASE | 221 | Q0VD86 | |
| WLQGEPPRMQDLIHG | 131 | Q9BQI9 | |
| MPQRGHPSQEGLWAL | 1 | Q8IYJ3 | |
| VPHRIWQNSLGMHPG | 226 | Q4G112 | |
| QLMCTAPPGAVQGHW | 221 | P07204 | |
| GENWPHLTRVTPMGG | 86 | Q8NEQ6 | |
| QVINPMGWDAFGLPA | 121 | Q15031 | |
| WNPATGASILPEHDM | 1256 | Q8NDG6 | |
| EMQGFGPSLPAWHLE | 436 | O43147 | |
| VLAGIPHGMRPQLWM | 111 | Q96HU1 | |
| HEVGWLPETQPQGSM | 271 | Q2M3G4 | |
| SKGMELPPVQDGHQW | 431 | Q9ULL8 | |
| GPLEDPSWALHSVMN | 156 | A6NM43 | |
| GPLEDPSWALHSVMN | 156 | Q96SF2 | |
| KGWMSVPGPQHTELA | 836 | Q92502 | |
| AWLQGTLLRNGPGMH | 26 | Q9HAY6 | |
| GWMPGREPTTHAEAQ | 536 | Q8IVF2 | |
| VMVPQWGTHQTVHLP | 2146 | Q6P2Q9 | |
| VPGFWANVIANHPQM | 161 | A0A494C1R9 | |
| GLPALLMGPAQHTSW | 11 | P52740 | |
| EQGQEPWMVEGANPH | 61 | Q5T5D7 | |
| VPGFWANVIANHPQM | 161 | P0CV99 | |
| WLPQNDLLGHPMTRA | 351 | Q9HAW8 | |
| QPMWEHRQPGVSGFT | 216 | Q8N2C7 | |
| GLPPESGGVMATQWQ | 461 | Q96K58 | |
| WQQHQGLLPPGMTID | 171 | Q2TAY7 | |
| WSIVEPPGSENGVMH | 281 | Q7Z6L1 | |
| VPLPGEMAQPWLHNV | 81 | Q4G0T1 | |
| QIAAHPWMLGADGGV | 286 | Q86V86 | |
| WLPQNDLLGHPMTRA | 351 | O60656 | |
| GTVWEEMLQTHLGPG | 821 | Q96JE7 | |
| LGKAGTHWEQGPNMP | 606 | Q3C1V9 | |
| DPWMVESGVPQGAHL | 71 | B4DU55 | |
| MGLPWGQPHLGLQML | 1 | Q9BT76 | |
| NAPWPIGVTMVGIHA | 276 | Q99633 | |
| WLDQTMEGGPPIVHC | 1006 | Q9HD43 | |
| WFLQHPPLMGQTEVQ | 2491 | Q6ZQQ6 | |
| VPNQPLGHGWMSHED | 261 | Q9UPU9 | |
| RGWLHPNDKVMGPGV | 146 | P29353 | |
| GTAFVQMPAHGLFPW | 916 | O14746 | |
| WLPQNDLLGHPMTRA | 351 | Q9HAW7 | |
| LSGHKQPDWRQNMGP | 26 | A6NP61 | |
| QDWGPGSMAHVSVVP | 276 | P78423 | |
| WLPQNDLLGHPMTRA | 351 | Q9HAW9 | |
| WLQQHPGGGIVSLFM | 56 | A0A0B4J266 | |
| PSWGTMEFPEHSQQL | 46 | Q9H5J0 | |
| NLRQVPWAGIGAMPA | 156 | Q6PJG9 | |
| PWAGIGAMPALHTLN | 161 | Q6PJG9 | |
| WTLPNGMHLEGPQTL | 2671 | Q9NR99 | |
| LSWKPPGQRGHEGIM | 656 | P52179 |